Listeria meningitis after treatment with infliximab

被引：62

作者：

Kamath, BM ^{[1
]}

Mamula, P ^{[1
]}

Baldassano, RN ^{[1
]}

Markowitz, JE ^{[1
]}

机构：

[1] Childrens Hosp Philadelphia, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA

来源：

关键词：

D O I：

10.1097/00005176-200204000-00018

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：410 / 412

页数：3

共 22 条

[1] *CDCP, 2001, DIV BACT MYC DIS DIS
[2] Chiba M, 1998, SCAND J GASTROENTERO, V33, P430
[3] Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease
Cornillie, F
Shealy, D
D'Haens, G
Geboes, K
Van Assche, G
Ceuppens, J
Wagner, C
Schaible, T
Plevy, SE
Targan, SR
Rutgeerts, P
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (04) : 463 - 473
[4] Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial
D'Haens, G
Van Deventer, S
Van Hogezand, R
Chalmers, D
Kothe, C
Baert, F
Braakman, T
Schaible, T
Geboes, K
Rutgeerts, P
[J]. GASTROENTEROLOGY, 1999, 116 (05) : 1029 - 1034
[5] LISTERIA-MONOCYTOGENES, A FOOD-BORNE PATHOGEN
FARBER, JM
PETERKIN, PI
[J]. MICROBIOLOGICAL REVIEWS, 1991, 55 (03) : 476 - 511
[6] Farrell RJ, 2000, AM J GASTROENTEROL, V95, P3490
[7] TUMOR-NECROSIS-FACTOR-ALPHA IS REQUIRED IN THE PROTECTIVE IMMUNE-RESPONSE AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE
FLYNN, JL
GOLDSTEIN, MM
CHAN, J
TRIEBOLD, KJ
PFEFFER, K
LOWENSTEIN, CJ
SCHREIBER, R
MAK, TW
BLOOM, BR
[J]. IMMUNITY, 1995, 2 (06) : 561 - 572
[8] *FOOD DRUG ASS CTR, 1999, STRUCT IN DAT SURV R
[9] HAVELL EA, 1989, J IMMUNOL, V143, P2894
[10] Use of infliximab in the treatment of Crohn's disease in children and adolescents
Hyams, JS
Markowitz, J
Wyllie, R
[J]. JOURNAL OF PEDIATRICS, 2000, 137 (02) : 192 - 196